The global interventional cardiology and endovascular medical sector continues to experience steady technological advancement. Sourcing high-grade equipment for targeted clinical treatments requires dependable partnerships with certified international producers. Medical device distributors and institutional procurement directors actively seek streamlined supply channels capable of matching demanding clinical specifications, precise delivery schedules, and scalable mass manufacturing capacities across diverse global markets.

Established as a prominent national high-tech enterprise, this organization specializes in the extensive research, development, precision production, and global commercialization of sophisticated cardiovascular and peripheral vascular intervention technologies. Operating from a modern industrial hub spanning over 5,000 square meters, the facility features fully certified Class 10,000 cleanroom environments designed strictly under GMP standards. The engineering architecture integrates advanced extrusion lines, laser welding technology, microscopic balloon assembly systems, and comprehensive chemical testing laboratories.

With robust international standard compliance, the product portfolio carries multiple ISO 13485 quality system certifications, CE mark approvals, and regulatory clearances across numerous overseas jurisdictions. The enterprise provides end-to-end technical production services, encompassing customized catheter shaft development, drug-coated balloon technologies, peripheral stent delivery platforms, and specialized vascular sheath assemblies engineered to enhance pushability, trackability, and crossability in complex endovascular procedures.